| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260060.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039509891 |
Resistant |
| ENSG00000260060.1 |
Bosutinib |
Skin cutaneous melanoma |
0.033091513 |
Resistant |
| ENSG00000260060.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.048424489 |
Sensitive |
